NCT00276484View on ClinicalTrials.gov

To Evaluate Ezetimibe Plus Atorvastatin Versus Atorvastatin in Patients With High Cholesterol Not Controlled on Atorvastatin 40 mg (0653-090)

PHASE3CompletedINTERVENTIONAL
Enrollment

579

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

February 29, 2008

Study Completion Date

March 31, 2008

Conditions
Hypercholesterolemia
Interventions
DRUG

atorvastatin

Atorvastatin 80 mg tablet by mouth, once a day for 6 weeks

DRUG

atorvastatin

Atorvastatin 40 mg by mouth, once a day for 6 weeks

DRUG

ezetimibe

Ezetimibe 10 mg tablets by mouth, once a day for 6 weeks.

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00276484 - To Evaluate Ezetimibe Plus Atorvastatin Versus Atorvastatin in Patients With High Cholesterol Not Controlled on Atorvastatin 40 mg (0653-090) | Biotech Hunter | Biotech Hunter